Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Hybridoma cell strain 2C1 capable of secreting CAV-2 monoclonal antibodies, monoclonal antibodies secreted by cell strain and application

A hybridoma cell line, CAV-2 technology, applied in the field of monoclonal antibodies

Inactive Publication Date: 2015-10-07
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the development of monoclonal antibody against CAV-2 and its diagnostic colloidal gold test strip

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hybridoma cell strain 2C1 capable of secreting CAV-2 monoclonal antibodies, monoclonal antibodies secreted by cell strain and application
  • Hybridoma cell strain 2C1 capable of secreting CAV-2 monoclonal antibodies, monoclonal antibodies secreted by cell strain and application
  • Hybridoma cell strain 2C1 capable of secreting CAV-2 monoclonal antibodies, monoclonal antibodies secreted by cell strain and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] The technical solution of the present invention will be further described below in conjunction with the accompanying drawings, but it is not limited thereto. Any modification or equivalent replacement of the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention should be covered by the present invention. within the scope of protection.

[0037] The invention provides a method for preparing anti-CAV-2 monoclonal antibodies that recognize different epitopes, the specific contents are as follows:

[0038] 1 Materials and methods

[0039] 1.1 Materials, experimental animals and reagents

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a hybridoma cell strain 2C1 capable of secreting CAV-2 monoclonal antibodies, the monoclonal antibodies secreted by the cell strain and application. The preservation number of the hybridoma cell strain 2C1 is CGMCC No. 10878. An indirect immunofluorescence result shows that the monoclonal antibodies secreted by the hybridoma cell strain 2C1 can specifically recognize CAV-2 viruses and do not react with MDCK (madin-darby canine kidney) cells. A result of a superposition experiment of the hybridoma cell strain 2C1 and two monoclonal antibodies secreted by another hybridoma cell strain shows that the two monoclonal antibodies are used for different antigenic epitopes of the CAV-2 viruses. The monoclonal antibody prepared by the invention can react with CAV-2 well and can be used for identifying a clinic isolated strain. The 2C1 monoclonal antibody and the 7D7 monoclonal antibody which are prepared by the invention are used for recognizing two different antigen determinants of the CAV-2, so that the monoclonal antibodies can be used for detecting preparation of CAV-2 pathogenic colloidal gold and establishment of a sandwiched ELISA (enzyme-linked immuno sorbent assay) method.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a hybridoma cell line secreting CAV-2 monoclonal antibody, the monoclonal antibody secreted by the cell line and application thereof. Background technique [0002] Adenovirus (Canln adenovll.us, CAV) is one of the viruses with the most detailed studies on biological characteristics such as morphological structure and gene replication mechanism. The capsid of adenovirus is composed of three main structural proteins: fibrils, hexons and pentons. It has strong infectivity, clear morphological structure, and is widely used in scientific research. Currently, the known serotypes of canine adenoviruses are type 1 and type 2. Although there is immune cross-protection between the two, they are different in pathogenic tropism. The homology of the adenovirus genomes of these two serotypes is between 57-70%. Canine adenovirus infection is a viral infectious disease of dogs, which mainly causes h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/20C07K16/08G01N33/577G01N33/569
Inventor 蔡雪辉王淑杰刘鹤刘永刚
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com